• OPEN AN ACCOUNT
Indian Indices
Nifty
25,549.00 304.25
(1.21%)
Sensex
83,924.98 169.11
( 0.20%)
Bank Nifty
57,206.70 585.55
( 1.03%)
Nifty IT
38,996.25 -50.05
( -0.13%)
Global Indices
Nasdaq
43,414.81 411.37
(0.96%)
Dow Jones
6,161.58 48.42
(0.79%)
Hang Seng
39,598.86 656.79
(1.69%)
Nikkei 225
8,735.60 16.85
(0.19%)
Forex
USD-INR
85.99 -0.05
(-0.06%)
EUR-INR
99.96 0.09
(0.09%)
GBP-INR
117.20 0.22
(0.18%)
JPY-INR
0.59 0.00
(-0.22%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5304659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
174.06
38.85
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

ashok leyl& ltd
Regent Enterprises reports standalone net loss of Rs 2.91 crore in the March 2025 quarter
May 29,2025
Net Loss of Regent Enterprises reported to Rs 2.91 crore in the quarter ended March 2025 as against net loss of Rs 0.09 crore during the previous quarter ended March 2024. Sales declined 12.73% to Rs 198.41 crore in the quarter ended March 2025 as against Rs 227.34 crore during the previous quarter ended March 2024.

For the full year,net profit rose 58.46% to Rs 1.03 crore in the year ended March 2025 as against Rs 0.65 crore during the previous year ended March 2024. Sales rose 11.38% to Rs 749.25 crore in the year ended March 2025 as against Rs 672.67 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales198.41227.34 -13 749.25672.67 11
OPM %-1.100.31 -0.770.08 -
PBDT-2.170.17 PL 5.810.64 808
PBT-2.300.03 PL 5.280.21 2414
NP-2.91-0.09 -3133 1.030.65 58